InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+14.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Sachs Jessica, Directeur Médical. Officer active across 1 company, notably Cogent Biosciences, Inc.. In total, 4 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €2.7m. Activity tracked since 31 December 2021. The latest transaction was filed on 26 December 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Sachs Jessica
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
82,642 shares@ US$38.7099.7% of flowCommon StockSEC:0001193125-25-337050:0
50,000 shares0Common StockSEC:0001193125-25-326773:0
622 shares@ US$7.3950.0001% mcap35.1% of flowCommon StockSEC:0000899243-22-024711:0
674 shares@ US$6.8170.0001% mcap32.4% of flowCommon StockSEC:0000899243-22-000694:0
4 of 4 declarations
About Sachs Jessica
Jessica Sachs is the Chief Medical Officer at Cogent Biosciences, Inc. She is responsible for leading the company's medical and scientific initiatives. Her expertise in biotechnology and clinical research is essential for the development of new treatments. She plays a key role in guiding Cogent Biosciences' medical strategies.
